PATHOLOGY & ONCOLOGY RESEARCHVol. 2 No. 3, 1996

 Article

Urinary Excretion of Thioamine Compounds in Patients with Malignant Tumors and Inflammation

Péter GERGELY1, Csaba VÉRTESI2

1Central Laboratory of Immunology, Semmelweis University of Medicine, Budapest, Hungary
2Chinoin Pharmacological and Chemical Works Co. Ltd., Budapest, Hungary

 

The Kokonov's reaction measures thioamine-like compounds excreted in the urine. We compared the results obtained by this reaction in patients with malignant tumors and inflammatory diseases. The majority of patients with advanced (stage III-IV) cancer displayed a positive test. The chance of obtaining a positive test was related to the tumor mass. Lymphoma patients in complete remission were negative. Patients suffering from bacterial infections, active autoimmune diseases, and acute pancreatitis or myocardial infarction also had positive tests. The increased excretion of thioamines, found in tumor-bearing patients can be explained by the activation of the immune system, probably by the inflammation around or within the tumor tissue. The Kokonov's reaction is not suitable to discriminate between tumor-bearing patients and healthy ones. It rather seems to be appropriate to assess inflammatory processes in infections and/or autoimmune diseases. Pathology & Oncology Research, Vol 2, Nr 3, 167-170, 1996

Key words: urinary thioamine; tumor; inflammation


Received: Jul 16, 1996; accepted: Aug 28, 1996
Correspondence: Péter GERGELY, Central Laboratory of Immunology, Semmelweis University of Medicine, Üllõi út 26. Budapest H-1085, Hungary; Tel: 36-1-139825

Click here to get the full-text version in PDF!
ad